SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000213
Filing Date
2021-11-01
Accepted
2021-11-01 08:00:17
Documents
16
Period of Report
2021-11-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20211101.htm   iXBRL 8-K 40333
2 EX-99.1 cmctypeameetingoutcomesv.htm EX-99.1 11889
6 GRAPHIC cmctypeameetingoutcomesv001.jpg GRAPHIC 286531
7 GRAPHIC cmctypeameetingoutcomesv002.jpg GRAPHIC 308699
8 GRAPHIC cmctypeameetingoutcomesv003.jpg GRAPHIC 280629
  Complete submission text file 0001485003-21-000213.txt   1405272

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20211101.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20211101_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20211101_pre.xml EX-101.PRE 13190
9 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20211101_htm.xml XML 11816
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211365337
SIC: 2834 Pharmaceutical Preparations